『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
〔閲覧〕【著作】
--- テーブル「著作」（著作（著書，論文，レター，国際会議など））は研究業績にかかる著作（著書，論文，レター，国際会議など）を登録するテーブルです．
登録情報
抽出条件
| OWN= |  福本 誠二
|
|---|
登録情報の数
有効な情報: 240件 + 無効な情報: 18件 = 全ての情報: 258件
全ての有効な情報 (240件)
条件追加
[種別](著作の種別)による分類 : | ||||||||||||||||||||
[言語](著作の言語)による分類 : | ||||||||||||||||||||
[カテゴリ](著作のカテゴリ)による分類 : | ||||||||||||||||||||
[共著種別](共著の種別)による分類 : | ||||||||||||||||||||
[学究種別](著作の学究種別)による分類 : | ||||||||||||||||||||
[組織](著作の帰属する組織)による分類 :
| ||||||||||||||||||||
[年月日](発行年月日)による分類
| ||||||||||||||||||||
抽出結果のリスト
-
排列順: 項目表示: T Shimada, S Mizutani, T Muto, T Yoneya, R Hino, S Takeda, Y Takeuchi, T Fujita, Seiji Fukumoto and T Yamashita : Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia., Proceedings of the National Academy of Sciences of the United States of America, Vol.98, No.11, 6500-6505, 2001. ... Miyuki Suzawa, Yasuhiro Tamura, Seiji Fukumoto, Kohei Miyazono, Toshiro Fujita, Shigeaki Kato and Yasuhiro Takeuchi : Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation., Journal of Bone and Mineral Research, Vol.17, No.2, 240-248, 2002. ... Yasuhiro Takeuchi, Seiji Fukumoto, Konosuke Nakayama, Yasuhiro Tamura, Akio Yanagisawa and Toshiro Fujita : Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors., Journal of Bone and Mineral Research, Vol.17, No.5, 753-757, 2002. ... Terumasa Nagase, Takehiko Murakami, Toshihiko Tsukada, Ryuichi Kitamura, Noriko Chikatsu, Hiroki Takeo, Nobuki Takata, Hiroko Yasuda, Seiji Fukumoto, Yuji Tanaka, Naokazu Nagata, Ken Yamaguchi, Takuhiko Akatsu and Michiko Yamamoto : A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor., The Journal of Clinical Endocrinology and Metabolism, Vol.87, No.6, 2681-2687, 2002. ... Seiji Fukumoto and Takeyoshi Yamashita : Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin., Current Opinion in Nephrology and Hypertension, Vol.11, No.4, 385-389, 2002. ... Noriko Chikatsu, Yasuhiro Takeuchi, Seiji Fukumoto, Kazuki Yano, Naoya Fujita, Takashi Tsuruo and Toshiro Fujita : Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro., Endocrine Journal, Vol.49, No.4, 439-447, 2002. ... Takashi Shimada, Takanori Muto, Itaru Urakawa, Takashi Yoneya, Yuji Yamazaki, Katsuya Okawa, Yasuhiro Takeuchi, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita : Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo., Endocrinology, Vol.143, No.8, 3179-3182, 2002. ... Sumiyo Watanabe, Seiji Fukumoto, Hangil Chang, Yasuhiro Takeuchi, Yukihiro Hasegawa, Ryo Okazaki, Noriko Chikatsu and Toshiro Fujita : Association between activating mutations of calcium-sensing receptor and Bartter's syndrome., The Lancet, Vol.360, No.9334, 692-694, 2002. ... Yuji Yamazaki, Ryo Okazaki, Minako Shibata, Yukihiro Hasegawa, Kohei Satoh, Toshihiro Tajima, Yasuhiro Takeuchi, Toshiro Fujita, Kazuhiko Nakahara, Takeyoshi Yamashita and Seiji Fukumoto : Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia., The Journal of Clinical Endocrinology and Metabolism, Vol.87, No.11, 4957-4960, 2002. ... Miho Honda, Seiji Fukumoto, Toshiro Fujita, Yoshitomo Oka and Tomoichiro Asano : Association of HLA-CW3 with type 1 diabetes mellitus and idiopathic hypoparathyroidism in the Japanese., Endocrine Journal, Vol.49, No.6, 653-654, 2002. ... Noriyuki Hanibuchi, Takao Maruyama, Masakazu Menju, Hiroyuki Toyoshima, Takehisa Yamamoto, Seiji Fukumoto and Ichiro Konishi : Marked hypercalcemia in a patient with hypocalciuric hypercalcemia without a mutation in the calcium-sensing receptor gene., Internal Medicine, Vol.41, No.12, 1153-1157, 2002. ... Yasuhiro Takeuchi, Sumiyo Watanabe, Genichiro Ishii, Shu Takeda, Konosuke Nakayama, Seiji Fukumoto, Yasuyuki Kaneta, Daisuke Inoue, Toshio Matsumoto, Kenichi Harigaya and Toshiro Fujita : Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice*, The Journal of Biological Chemistry, Vol.277, No.50, 49011-49018, 2002. ... Sumiyo Watanabe, Yasuhiro Takeuchi, Seiji Fukumoto, Hiroko Fujita, Tadasumi Nakano and Toshiro Fujita : Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients., Journal of Bone and Mineral Metabolism, Vol.21, No.3, 166-171, 2003. ... Noriko Chikatsu, Sumiyo Watanabe, Yasuhiro Takeuchi, Yasushi Muraosa, Shinsuke Sasaki, Yuji Oka, Seiji Fukumoto and Toshiro Fujita : A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene., Endocrine Journal, Vol.50, No.1, 91-96, 2003. ... Konosuke Nakayama, Yasuhiro Tamura, Miyuki Suzawa, Shun-Ichi Harada, Seiji Fukumoto, Mitsuyasu Kato, Kohei Miyazono, Gideon A. Rodan, Yasuhiro Takeuchi and Toshiro Fujita : Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells., Journal of Bone and Mineral Research, Vol.18, No.5, 827-835, 2003. ... Seiji Fukumoto and Takeyoshi Yamashita : Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia., The New England Journal of Medicine, Vol.349, No.5, 505-6;authorreply5056, 2003. ... Emiko Tohjima, Daisuke Inoue, Nobuchika Yamamoto, Shinsuke Kido, Yuji Ito, Shuji Kato, Yasuhiro Takeuchi, Seiji Fukumoto and Toshio Matsumoto : Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice, Journal of Bone and Mineral Research, Vol.18, No.8, 1461-1470, 2003. ... Takashi Shimada, Hisashi Hasegawa, Yuji Yamazaki, Takanori Muto, Rieko Hino, Yasuhiro Takeuchi, Toshiro Fujita, Kazuhiko Nakahara, Seiji Fukumoto and Takeyoshi Yamashita : FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis., Journal of Bone and Mineral Research, Vol.19, No.3, 429-435, 2003. ... Takashi Shimada, Makoto Kakitani, Yuji Yamazaki, Hisashi Hasegawa, Yasuhiro Takeuchi, Toshiro Fujita, Seiji Fukumoto, Kazuma Tomizuka and Takeyoshi Yamashita : Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism., The Journal of Clinical Investigation, Vol.113, No.4, 561-568, 2004. ... Takashi Shimada, Itaru Urakawa, Yuji Yamazaki, Hisashi Hasegawa, Rieko Hino, Takashi Yoneya, Yasuhiro Takeuchi, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita : FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa., Biochemical and Biophysical Research Communications, Vol.314, No.2, 409-414, 2004. ... Hiroyuki Yamashita, Takeyoshi Yamashita, Masashi Miyamoto, Takashi Shigematsu, Junichiro James Kazama, Takashi Shimada, Yuji Yamazaki, Seiji Fukumoto, Masafumi Fukagaw and Shiro Noguchi : Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism., European Journal of Endocrinology, Vol.151, No.1, 55-60, 2004. ... Yasuhiro Takeuchi, Hisanori Suzuki, Sayoko Ogura, Rie Imai, Yuji Yamazaki, Takeyoshi Yamashita, Yoshinari Miyamoto, Hiroshi Okazaki, Kozo Nakamura, Kazuhiko Nakahara, Seiji Fukumoto and Toshiro Fujita : Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia., The Journal of Clinical Endocrinology and Metabolism, Vol.89, No.8, 3979-3982, 2004. ... Takashi Shigematsu, Junichiro James Kazama, Takeyoshi Yamashita, Seiji Fukumoto, Tatsuo Hosoya, Fumitake Gejyo and Masafumi Fukagawa : Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency., American Journal of Kidney Diseases, Vol.44, No.2, 250-256, 2004. ... Nobuhiro Fukushima, Reiko Hanada, Hitoshi Teranishi, Yoshihiko Fukue, Toshiaki Tachibana, Hiroshi Ishikawa, Shu Takeda, Yasuhiro Takeuchi, Seiji Fukumoto, Kenji Kangawa, Kensei Nagata and Masayasu Kojima : Ghrelin directly regulates bone formation., Journal of Bone and Mineral Research, Vol.20, No.5, 790-798, 2004. ... Nobuaki Ito, Seiji Fukumoto, Yasuhiro Takeuchi, Toshiyuki Yasuda, Yukihiro Hasegawa, Fumi Takemoto, Toshihiro Tajima, Kazushige Dobashi, Yuji Yamazaki, Takeyoshi Yamashita and Toshiro Fujita : Comparison of two assays for fibroblast growth factor (FGF)-23., Journal of Bone and Mineral Metabolism, Vol.23, No.6, 435-440, 2005. ... Shohei Nakanishi, Junichiro James Kazama, Tomoko Nii-Kono, Kentaro Omori, Takeyoshi Yamashita, Seiji Fukumoto, Fumitake Gejyo, Takashi Shigematsu and Masafumi Fukagawa : Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients., Kidney International, Vol.67, No.3, 1171-1178, 2005. ... Junichiro J. Kazama, Fuminori Sato, Kentaro Omori, Hitomi Hama, Suguru Yamamoto, Hiroki Maruyama, Ichiei Narita, Fumitake Gejyo, Takeyoshi Yamashita, Seiji Fukumoto and Masafumi Fukagawa : Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients., Kidney International, Vol.67, No.3, 1120-1125, 2005. ... Hiroyuki Yamashita, Yuji Yamazaki, Hisashi Hasegawa, Takeyoshi Yamashita, Seiji Fukumoto, Takashi Shigematsu, Junichiro James Kazama, Masafumi Fukagawa and Shiro Noguchi : Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation., The Journal of Clinical Endocrinology and Metabolism, Vol.90, No.7, 4211-4215, 2005. ... Hiroshi Nishi, Tomoko Nii-Kono, Shohei Nakanishi, Yuji Yamazaki, Takeyoshi Yamashita, Seiji Fukumoto, Kazuto Ikeda, Akira Fujimori and Masafumi Fukagawa : Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism., Nephron. Clinical Practice, Vol.101, No.2, c94-9, 2005. ... Takashi Shimada, Yuji Yamazaki, Motoo Takahashi, Hisashi Hasegawa, Itaru Urakawa, Takeshi Oshima, Kaori Ono, Makoto Kakitani, Kazuma Tomizuka, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita : Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism., American Journal of Physiology, Renal Physiology, Vol.289, No.5, F1088-95, 2005. ... Kaori Araya, Seiji Fukumoto, Rebecca Backenroth, Yasuhiro Takeuchi, Kounosuke Nakayama, Nobuaki Ito, Nozomi Yoshii, Yuji Yamazaki, Takeyoshi Yamashita, Justin Silver, Takashi Igarashi and Toshiro Fujita : A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis., The Journal of Clinical Endocrinology and Metabolism, Vol.90, No.10, 5523-5527, 2005. ... Seiji Fukumoto : Post-translational modification of Fibroblast Growth Factor 23., Therapeutic Apheresis and Dialysis, Vol.9, No.4, 319-322, 2005. ... Noriko Makita, Taroh Iiri, Junichiro Sato, Seiji Fukumoto, Tomoki Okazaki, Kiyomi Yamazaki, Takao Obara and Toshiro Fujita : An instructive case suggesting cyclical primary hyperparathyroidism., Endocrine Journal, Vol.53, No.3, 311-316, 2006. ... Yusuke Shinoda, Masayuki Yamaguchi, Naoshi Ogata, Toru Akune, Naoto Kubota, Toshimasa Yamauchi, Yasuo Terauchi, Takashi Kadowaki, Yasuhiro Takeuchi, Seiji Fukumoto, Toshiyuki Ikeda, Kazuto Hoshi, Ung-il Chung, Kozo Nakamura and Hiroshi Kawaguchi : Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways., Journal of Cellular Biochemistry, Vol.99, No.1, 196-208, 2006. ... Itaru Urakawa, Yuji Yamazaki, Takashi Shimada, Kousuke Iijima, Hisashi Hasegawa, Katsuya Okawa, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita : Klotho converts canonical FGF receptor into a specific receptor for FGF23., Nature, Vol.444, No.7120, 770-774, 2006. ... Seiji Fukumoto and Takeyoshi Yamashita : FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23., Bone, Vol.40, No.5, 1190-1195, 2007. ... Yaacov Frishberg, Nobuaki Ito, Choni Rinat, Yuji Yamazaki, Sofia Feinstein, Itaru Urakawa, Paulina Navon-Elkan, Rachel Becker-Cohen, Takeyoshi Yamashita, Kaori Araya, Takashi Igarashi, Toshiro Fujita and Seiji Fukumoto : Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23., Journal of Bone and Mineral Research, Vol.22, No.2, 235-242, 2007. ... Nobuaki Ito, Seiji Fukumoto, Manabu Taguchi, Akira Takeshita, Yasuhiro Takeuchi, Shozo Yamada and Toshiro Fujita : Fibroblast growth factor (FGF)23 in patients with acromegaly., Endocrine Journal, Vol.54, No.3, 481-484, 2007. ... Hiroyuki Yamashita, Yuji Yamazaki, Hisashi Hasegawa, Takeyoshi Yamashita, Seiji Fukumoto, Takashi Shigematsu, Junichiro James Kazama, Masafumi Fukagawa and Shiro Noguchi : Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation., Endocrine Journal, Vol.54, No.3, 465-470, 2007. ... Seiji Fukumoto : Actions and mode of actions of FGF19 subfamily members., Endocrine Journal, Vol.55, No.1, 23-31, 2007. ... Hiroo Kawarazaki, Yugo Shibagaki, Hideki Shimizu, Wakako Kawarazaki, Nobuaki Ito, Akira Ishikawa, Seiji Fukumoto and Toshiro Fujita : Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia., Clinical and Experimental Nephrology, Vol.11, No.3, 255-257, 2007. ... Nobuaki Ito, Seiji Fukumoto, Yasuhiro Takeuchi, Shu Takeda, Hisanori Suzuki, Takeyoshi Yamashita and Toshiro Fujita : Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans., Journal of Bone and Mineral Metabolism, Vol.25, No.6, 419-422, 2007. ... Seiji Fukumoto : Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23., Internal Medicine, Vol.47, No.5, 337-343, 2008. ... Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Hiroyuki Tanaka, Daisuke Inoue, Masanori Minagawa, Toshitsugu Sugimoto, Mika Yamauchi, Toshimi Michigami and Toshio Matsumoto : Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement., Bone, Vol.42, No.6, 1235-1239, 2008. ... Eriko Ogura, Kazunori Kageyama, Seiji Fukumoto, Norito Yagihashi, Yoshiko Fukuda, Toru Kikuchi, Mitsuo Masuda and Toshihiro Suda : Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23., Internal Medicine, Vol.47, No.7, 637-641, 2008. ... Tetsushi Nasu, Seigo Kurisu, Shohei Matsuno, Kunihiro Tatsumi, Tetsuhiro Kakimoto, Masato Kobayashi, Yoshio Nakano, Hisao Wakasaki, Hiroto Furuta, Masahiro Nishi, Hideyuki Sasaki, Hisanori Suzuki, Nobuaki Ito, Seiji Fukumoto and Kishio Nanjo : Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23., Internal Medicine, Vol.47, No.10, 957-961, 2008. ... Yuji Yamazaki, Taro Tamada, Noriyuki Kasai, Itaru Urakawa, Yukiko Aono, Hisashi Hasegawa, Toshiro Fujita, Ryota Kuroki, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada : Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23., Journal of Bone and Mineral Research, Vol.23, No.9, 1509-1518, 2008. ... Shingo Sato, Ayako Kimura, Jerfi Ozdemir, Yoshinori Asou, Makiko Miyazaki, Tetsuya Jinno, Keisuke Ae, Xiuyun Liu, Mitsuhiko Osaki, Yasuhiro Takeuchi, Seiji Fukumoto, Hiroshi Kawaguchi, Hirotaka Haro, Ken-Ichi Shinomiya, Gerard Karsenty and Shu Takeda : The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease., Arthritis and Rheumatism, Vol.58, No.9, 2764-2775, 2008. ... Seiji Fukumoto : The role of bone in phosphate metabolism., Molecular and Cellular Endocrinology, Vol.310, No.1-2, 63-70, 2008. ... Tasuku Saito, Seiji Fukumoto, Nobuaki Ito, Hisanori Suzuki, Takashi Igarashi and Toshiro Fujita : A novel mutation in the GATA3 gene of a Japanese patient with PTH-deficient hypoparathyroidism., Journal of Bone and Mineral Metabolism, Vol.27, No.3, 386-389, 2008. ... Seiji Fukumoto and T John Martin : Bone as an endocrine organ., Trends in Endocrinology and Metabolism, Vol.20, No.5, 230-236, 2009. ... Yuichiro Shimizu, Yuko Tada, Mika Yamauchi, Takaaki Okamoto, Hisanori Suzuki, Nobuaki Ito, Seiji Fukumoto, Toshitsugu Sugimoto and Toshiro Fujita : Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia., Bone, Vol.45, No.4, 814-816, 2009. ... Tasuku Saito, Yutaka Nishii, Toshiyuki Yasuda, Nobuaki Ito, Hisanori Suzuki, Takashi Igarashi, Seiji Fukumoto and Toshiro Fujita : Familial hypophosphatemic rickets caused by a large deletion in PHEX gene., European Journal of Endocrinology, Vol.161, No.4, 647-651, 2009. ... Tasuku Saito and Seiji Fukumoto : Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism., International Journal of Pediatric Endocrinology, Vol.2009, (号), 496514, 2009. ... Yukiko Aono, Yuji Yamazaki, Junichi Yasutake, Takehisa Kawata, Hisashi Hasegawa, Itaru Urakawa, Toshiro Fujita, Michihito Wada, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada : Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia., Journal of Bone and Mineral Research, Vol.24, No.11, 1879-1888, 2009. ... Hiroyuki Inose, Hiroki Ochi, Ayako Kimura, Koji Fujita, Ren Xu, Shingo Sato, Makiko Iwasaki, Satoko Sunamura, Yasuhiro Takeuchi, Seiji Fukumoto, Kuniaki Saito, Takashi Nakamura, Haruhiko Siomi, Hiroshi Ito, Yoshiyasu Arai, Ken-ichi Shinomiya and Shu Takeda : A microRNA regulatory mechanism of osteoblast differentiation., Proceedings of the National Academy of Sciences of the United States of America, Vol.106, No.49, 20794-20799, 2009. ... Ayako Kimura, Hiroyuki Inose, Fumiko Yano, Koji Fujita, Toshiyuki Ikeda, Shingo Sato, Makiko Iwasaki, Tetsuya Jinno, Keisuke Ae, Seiji Fukumoto, Yasuhiro Takeuchi, Hiroshi Itoh, Takeshi Imamura, Hiroshi Kawaguchi, Ung-il Chung, James F. Martin, Sachiko Iseki, Ken-ichi Shinomiya and Shu Takeda : Runx1 and Runx2 cooperate during sternal morphogenesis., Development, Vol.137, No.7, 1159-1167, 2010. ... Yoshiyuki Mori, Toru Ogasawara, Toru Motoi, Yuichiro Shimizu, Daichi Chikazu, Kazumi Tamura, Seiji Fukumoto and Tsuyoshi Takato : Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature., Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, Vol.109, No.3, e57-63, 2010. ... (未承認) 福本 誠二 : Disorders of phosphate metabolism, Rinsho byori. The Japanese journal of clinical pathology, Vol.58, No.3, 225-231, 2010年3月. ... Michiko Hori, Noriko Makita, Takahiro Andoh, Hirotoshi Takiyama, Yuki Yajima, Takashi Sakatani, Seiji Fukumoto, Taroh Iiri and Toshiro Fujita : Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis., Endocrine Journal, Vol.57, No.6, 485-492, 2010. ... (未承認) 福本 誠二 : [FGF23]., Nippon rinsho. Japanese journal of clinical medicine, Vol.68 Suppl 7, (号), 645-647, 2010年. ... (未承認) 福本 誠二 : [Endocrine diseases]., Nippon rinsho. Japanese journal of clinical medicine, Vol.68 Suppl 8, (号), 354-358, 2010年8月. ... Hisashi Hasegawa, Nobuo Nagano, Itaru Urakawa, Yuji Yamazaki, Kousuke Iijima, Toshiro Fujita, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada : Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease., Kidney International, Vol.78, No.10, 975-980, 2010. ... (未承認) 福本 誠二 : [Various functions of cytokines in metabolism of bones and cartilage]., (発行所), (都市), 2010年10月. ... (未承認) N. Ito, Y. Shimizu, H. Suzuki, T. Saito, T. Okamoto, M. Hori, M. Akahane, Seiji Fukumoto and T. Fujita : Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia: Letter to the Editor, Journal of Internal Medicine, Vol.268, No.4, 390-394, 2010. ... Michiko Hori, Yuichiro Shimizu and Seiji Fukumoto : Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism., Endocrinology, Vol.152, No.1, 4-10, 2010. ... (未承認) 福本 誠二 : [Antagonist for calcium-sensing receptor. JTT-305/MK-5442]., Clinical calcium, Vol.21, No.1, 89-93, 2011年1月. ... Hiroo Kawarazaki, Yugo Shibagaki, Seiji Fukumoto, Ryo Kido, Ichiro Nakajima, Shohei Fuchinoue, Toshiro Fujita, Masafumi Fukagawa and Satoshi Teraoka : The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study., Nephrology, Dialysis, Transplantation, Vol.26, No.8, 2691-2695, 2011. ... (未承認) 福本 誠二 : [Differential diagnosis of hypercalcemia]., Nihon rinsho. Japanese journal of clinical medicine, Vol.69 Suppl 2, (号), 435-439, 2011年3月. ... Yukiko Aono, Hisashi Hasegawa, Yuji Yamazaki, Takashi Shimada, Toshiro Fujita, Takeyoshi Yamashita and Seiji Fukumoto : Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice., Journal of Bone and Mineral Research, Vol.26, No.4, 803-810, 2011. ... Hiroo Kawarazaki, Yugo Shibagaki, Seiji Fukumoto, Ryo Kido, Katsuyuki Ando, Ichiro Nakajima, Shohei Fuchinoue, Toshiro Fujita, Masafumi Fukagawa and Satoshi Teraoka : Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study., Therapeutic Apheresis and Dialysis, Vol.15, No.5, 481-487, 2011. ... Takeshi Uno, Kensuke Kawai, Naoto Kunii, Seiji Fukumoto, Junji Shibahara, Toru Motoi and Nobuhito Saito : Osteomalacia caused by skull base tumors: report of 2 cases., Neurosurgery, Vol.69, No.1, E239-44;discussionE244, 2011. ... Tasuku Saito, Yuichiro Shimizu, Michiko Hori, Manabu Taguchi, Takashi Igarashi, Seiji Fukumoto and Toshiro Fujita : A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene., Bone, Vol.49, No.4, 913-916, 2011. ... Seiji Fukumoto and Yuichiro Shimizu : Fibroblast growth factor 23 as a phosphotropic hormone and beyond., Journal of Bone and Mineral Metabolism, Vol.29, No.5, 507-514, 2011. ... Yuichiro Shimizu, Seiji Fukumoto and Toshiro Fujita : Evaluation of a new automated chemiluminescence immunoassay for FGF23., Journal of Bone and Mineral Metabolism, Vol.30, No.2, 217-221, 2011. ... (未承認) Yumie Wada, Yuka Kinoshita, Manabu Taguchi, 福本 誠二, Toshiro Fujita : [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide]., Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Vol.100, No.10, 3031-3033, 2011年. ... (未承認) 福本 誠二 : [Physiological and pathophygiological significance of a phosphotropic hormone, FGF23]., Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Vol.100, No.12, 3649-3654, 2011年12月. ... Takashi Shimada and Seiji Fukumoto : FGF23 as a novel therapeutic target., Advances in Experimental Medicine and Biology, Vol.728, 158-170, 2012. ... (未承認) Yuka Kinoshita, 福本 誠二 : [Parathyroid hormone for disorders of calcium metabolism and metabolic bone diseases other than osteoporosis]., Clinical calcium, Vol.22, No.3, 381-386, 2012年3月. ... Yuka Kinoshita, Tasuku Saito, Yuichiro Shimizu, Michiko Hori, Manabu Taguchi, Takashi Igarashi, Seiji Fukumoto and Toshiro Fujita : Mutational analysis of patients with FGF23-related hypophosphatemic rickets., European Journal of Endocrinology, Vol.167, No.2, 165-172, 2012. ... Hiroo Kawarazaki, Yugo Shibagaki, Ryo Kido, Ichiro Nakajima, Shohei Fuchinoue, Katsuyuki Ando, Toshiro Fujita, Masafumi Fukagawa, Satoshi Teraoka and Seiji Fukumoto : Kidney transplantation restored uncoupled bone turnover in end-stage renal disease., Clinical Nephrology, Vol.78, No.1, 10-16, 2012. ... (未承認) 福本 誠二 : [Kidney and bone update : the 5-year history and future of CKD-MBD. CKD-MBD and phosphotropic hormones]., Clinical calcium, Vol.22, No.7, 987-991, 2012年7月. ... Seiji Fukumoto : What's new in FGF23 research?, BoneKEy Reports, Vol.1, (号), 111, 2012. ... Sunao Yamamoto, Yosuke Okada, Hiroko Mori, Seiji Fukumoto and Yoshiya Tanaka : Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide., Internal Medicine, Vol.51, No.17, 2375-2378, 2012. ... (未承認) 福本 誠二 : [Significance of FGF23 measurement]., Clinical calcium, Vol.22, No.10, 1525-1529, 2012年10月. ... Kate Vandyke, Stephen Fitter, Jenny Drew, Seiji Fukumoto, G Christopher Schultz, A Natalie Sims, T David Yeung, P Timothy Hughes and W Andrew C Zannettino : Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects., The Journal of Clinical Endocrinology and Metabolism, Vol.98, No.1, 67-76, 2012. ... (未承認) Yuka Kinoshita, 福本 誠二 : [Space flight/bedrest immobilization and bone. Medical treatment for immobilization osteoporosis]., Clinical calcium, Vol.22, No.12, 1895-1901, 2012年12月. ... (未承認) Kumiko Tanaka, Daigoro Hirohama, Midori Shirota, Yuzaburo Uetake, Manabu Taguchi, Koji Takano, 福本 誠二, Toshiro Fujita : [Case report ; a case of Bardet-Biedl syndrome with a pituitary tumor and growth hormone deficiency]., Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Vol.102, No.3, 704-707, 2013年. ... Masafumi Fukagawa, Keitaro Yokoyama, Fumihiko Koiwa, Masatomo Taniguchi, Tetsuo Shoji, James Junichiro Kazama, Hirotaka Komaba, Ryoichi Ando, Takatoshi Kakuta, Hideki Fujii, Msasaaki Nakayama, Yugo Shibagaki, Seiji Fukumoto, Naohiko Fujii, Motoshi Hattori, Akira Ashida, Kunitoshi Iseki, Takashi Shigematsu, Yusuke Tsukamoto, Yoshiharu Tsubakihara, Tadashi Tomo, Hideki Hirakata and Tadao Akizawa : Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder., Therapeutic Apheresis and Dialysis, Vol.17, No.3, 247-288, 2013. ... (未承認) Yuka Kinoshita, 福本 誠二 : [Antagonists of Wnt pathway]., Clinical calcium, Vol.23, No.6, 817-823, 2013年6月. ... (未承認) Seiji Fukumoto : Clinical Aspects of Fibroblast Growth Factor 23, (発行所), (都市), Aug. 2013. ... (未承認) 福本 誠二 : [Secondary osteoporosis or secondary contributors to bone loss in fracture. Endocrinological aspects of bone metabolism]., Clinical calcium, Vol.23, No.9, 1259-1264, 2013年9月. ... Takaaki Okamoto, Manabu Taguchi, Tomoko Osaki, Seiji Fukumoto and Toshiro Fujita : Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation., Journal of Bone and Mineral Metabolism, Vol.32, No.4, 393-399, 2013. ... (未承認) 福本 誠二 : [New concept on old disease. Preface]., (発行所), (都市), 2013年10月. ... Rika Jimbo, Fumiko Kawakami-Mori, Shengyu Mu, Daigoro Hirohama, Bohumil Majtan, Yuichiro Shimizu, Yutaka Yatomi, Seiji Fukumoto, Toshiro Fujita and Tatsuo Shimosawa : Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency., Kidney International, Vol.85, No.5, 1103-1111, 2013. ... Yuka Kinoshita, Michiko Hori, Manabu Taguchi, Sumiyo Watanabe and Seiji Fukumoto : Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia., The Journal of Clinical Endocrinology and Metabolism, Vol.99, No.2, E363-8, 2013. ... (未承認) 福本 誠二 : FGF23 in CKD-MBD, Japanese Journal of Nephrology, Vol.56, No.8, 1210-1217, 2014年. ... (未承認) 福本 誠二 : Recent progress and problem of treatment with active vitamin D, Clinical calcium, Vol.24, No.1, 53-58, 2014年1月. ... (未承認) 福本 誠二 : [Ectopic calcification]., Clinical calcium, Vol.24, No.2, 185-189, 2014年2月. ... Seiji Fukumoto : Phosphate metabolism and vitamin D., BoneKEy Reports, Vol.3, 497, 2014. ... Takeshi Nakamura, Toshimi Aizawa, Takeshi Hoshikawa, Hiroshi Ozawa, Nobuaki Ito, Seiji Fukumoto, Eiji Itoi and Shoichi Kokubun : Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine., Journal of Orthopaedic Science, Vol.20, No.4, 765-771, 2014. ... Seiji Fukumoto : Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia., Endocrinology and Metabolism, Vol.29, No.2, 136-143, 2014. ... Shinji Takeyari, Takehisa Yamamoto, Yuka Kinoshita, Seiji Fukumoto, H Francis Glorieux, Toshimi Michigami, Kosei Hasegawa, Taichi Kitaoka, Takuo Kubota, Yasuo Imanishi, Tsunesuke Shimotsuji and Keiichi Ozono : Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome., Bone, Vol.67, 56-62, 2014. ... Seiji Fukumoto : Anti-fibroblast growth factor 23 antibody therapy., Current Opinion in Nephrology and Hypertension, Vol.23, No.4, 346-351, 2014. ... Seiji Fukumoto : What can FGF23 do without Klotho?, BoneKEy Reports, Vol.3, 551, 2014. ... Yuka Kinoshita, Michiko Hori, Manabu Taguchi and Seiji Fukumoto : Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia., Bone, Vol.67, 145-151, 2014. ... (未承認) Yuka Kinoshita, 福本 誠二 : [Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia]., Clinical calcium, Vol.24, No.8, 1217-1222, 2014年8月. ... (未承認) 福本 誠二 : [Derangements of mineral metabolism associated with tumors]., Clinical calcium, Vol.24, No.8, 1153-1158, 2014年8月. ... (未承認) 福本 誠二 : Updates on Lifestyle-Related Diseases and Bone Metabolism. Teriparatide for osteoporosis associated with lifestyle-related diseases, Clinical calcium, Vol.24, No.11, 1701-1705, 2014年. ... (未承認) 福本 誠二 : Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases, Clinical calcium, Vol.25, No.1, 37-44, 2015年1月. ... Tomofumi Okamiya, Katsumasa Takahashi, Hideo Kamada, Junko Hirato, Toru Motoi, Seiji Fukumoto and Kazuaki Chikamatsu : Oncogenic osteomalacia caused by an occult paranasal sinus tumor., Auris, Nasus, Larynx, Vol.42, No.2, 167-169, 2015. ... (未承認) 福本 誠二 : Current Topics on Vitamin D. Cross talks among vitamin D endocrine system, PTH and FGF23, Clinical calcium, Vol.25, No.3, 341-347, 2015年3月. ... Michiko Hori, Yuka Kinoshita, Manabu Taguchi and Seiji Fukumoto : Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells., Journal of Bone and Mineral Metabolism, Vol.34, No.2, 132-139, 2015. ... (未承認) 福本 誠二 : Vascular Calcification - Pathological Mechanism and Clinical Application - . Regulation of mineral metabolism and mineralization by FGF23, Clinical calcium, Vol.25, No.5, 687-691, 2015年5月. ... Shogo Tajima, Yuichi Takashi, Nobuaki Ito, Seiji Fukumoto and Masashi Fukuyama : ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors., Medical Molecular Morphology, (巻), (号), (頁), 2015. ... (未承認) Yuichi Takashi, 福本 誠二 : Bone and Nutrition. The relationship between iron and phosphate metabolism, Clinical calcium, Vol.25, No.7, 1037-1042, 2015年7月. ... Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Daisuke Inoue, Ryo Okazaki, Mika Yamauchi, Toshitsugu Sugimoto, Masanori Minagawa, Toshimi Michigami, Masaki Nagai and Toshio Matsumoto : Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment., Endocrine Journal, Vol.62, No.9, 811-816, 2015. ... Seiji Fukumoto : FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism., Calcified Tissue International, Vol.98, No.4, 334-340, 2015. ... Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami, Masanori Minagawa, Ryo Okazaki, Toshitsugu Sugimoto, Yasuhiro Takeuchi and Toshio Matsumoto : Pathogenesis and diagnostic criteria for rickets and osteomalacia - proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society., Endocrine Journal, Vol.62, No.8, 665-671, July 2015. ... Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami, Masanori Minagawa, Ryo Okazaki, Toshitsugu Sugimoto, Yasuhiro Takeuchi and Toshio Matsumoto : Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society., Journal of Bone and Mineral Metabolism, Vol.33, No.5, 467-473, 2015. ... Yuichi Takashi, Yuka Kinoshita, Noriko Makita, Manabu Taguchi, Katsutoshi Takahashi, Masaomi Nangaku and Seiji Fukumoto : Rapid Recovery of Hypothalamic-Pituitary Axis after Successful Resection of an ACTH-secreting Neuroendocrine Tumor., Internal Medicine, Vol.54, No.17, 2201-2205, 2015. ... (未承認) 福本 誠二 : PTH preparations, Nihon rinsho. Japanese journal of clinical medicine, Vol.73, No.10, 1696-1700, 2015年. ... (未承認) Yuichi Takashi and Seiji Fukumoto : FGF23-klotho axis in CKD, Renal Replacement Therapy, Vol.2, No.1, 1-5, Jan. 2016. ... (未承認) 福本 誠二 : Many faces of phosphate, (発行所), (都市), 2016年2月. ... Yuka Kinoshita, Makoto Arai, Nobuaki Ito, Yuichi Takashi, Noriko Makita, Masaomi Nangaku, Yusuke Shinoda and Seiji Fukumoto : High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors., Endocrine Journal, Vol.63, No.5, 479-484, 2016. ... (未承認) Yuichi Takashi, 福本 誠二, Toshio Matsumoto : Vitamin D and osteoimmunology, Clinical calcium, Vol.26, No.5, 743-749, 2016年5月. ... (未承認) Yuichi Takashi and Seiji Fukumoto : FGF23Klotho axis in CKD, Renal Replacement Therapy, Vol.2, No.1, (頁), May 2016. ... (未承認) 福本 誠二 : FGF23 and osteonetwork, Clinical calcium, Vol.26, No.8, 1143-1147, 2016年. ... Yuichi Takashi, Yuka Kinoshita, Michiko Hori, Nobuaki Ito, Manabu Taguchi and Seiji Fukumoto : Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy., Endocrine Research, Vol.42, No.2, 132-137, 2016. ... Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi, Masanori Minagawa, Toshimi Michigami, Yasuhiro Takeuchi, Toshio Matsumoto and Toshitsugu Sugimoto : Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]., Journal of Bone and Mineral Metabolism, Vol.35, No.1, 1-5, Nov. 2016. ... Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi, Masanori Minagawa, Toshimi Michigami, Yasuhiro Takeuchi, Toshio Matsumoto and Toshitsugu Sugimoto : Assessment criteria for vitamin D deficiency/insufficiency in Japan - proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society [Opinion]., Endocrine Journal, Vol.64, No.1, 1-6, Dec. 2016. ... Yuichi Takashi, Yuka Kinoshita, Nobuaki Ito, Manabu Taguchi, Masaaki Takahashi, Naoya Egami, Shogo Tajima, Masaomi Nangaku and Seiji Fukumoto : Tumor-induced Osteomalacia Caused by a Parotid Tumor., Internal Medicine, Vol.56, No.5, 535-539, 2017. ... Yuka Kinoshita, Nobuaki Ito, Noriko Makita, Masaomi Nangaku and Seiji Fukumoto : Changes in bone metabolic parameters following oral calcium supplementation in an adult patient with vitamin D-dependent rickets type 2A., Endocrine Journal, Vol.64, No.6, 589-596, 2017. ... Seiji Fukumoto and Toshio Matsumoto : Recent advances in the management of osteoporosis., F1000Research, Vol.6, (号), 625, May 2017. ... 福本 誠二 : [Aging and homeostasis. Calcium metabolism and aging.], Clinical Calcium, Vol.27, No.7, 941-945, 2017年7月. ... Salvatore Minisola, Munro Peacock, Seiji Fukumoto, Cristiana Cipriani, Jessica Pepe, Harsha Sri Tella and T Michael Collins : Tuour-induced osteomalacia, Nature Reviews. Disease Primers, Vol.3, 17004, 2017. ... Taijun Hana, Shota Tanaka, Hirofumi Nakatomi, Masaaki Shojima, Seiji Fukumoto, Masako Ikemura and Nobuhito Saito : Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23., Endocrine Journal, Vol.64, No.10, 1033-1039, 2017. ... Ryuichi Watanabe, Nobuyuki Fujita, Yuiko Sato, Tami Kobayashi, Mayu Morita, Takatsugu Oike, Kana Miyamoto, Makoto Kuro-O, Toshimi Michigami, Seiji Fukumoto, Takashi Tsuji, Yoshiaki Toyama, Masaya Nakamura, Morio Matsumoto and Takeshi Miyamoto : Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions., Scientific Reports, Vol.7, No.1, 7786, 2017. ... Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, Kana Morimoto, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Kohhei Nakajima, Yoshifumi Mizobuchi, Shinji Nagahiro, Masahiro Abe and Seiji Fukumoto : Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review., Internal Medicine, Vol.56, No.18, 2455-2461, 2017. ... Hiroshi Kobayashi, Nobuaki Ito, Toru Akiyama, Tomotake Okuma, Yuka Kinoshita, Masachika Ikegami, Yusuke Shinoda, Seiji Fukumoto, Sakae Tanaka and Hirotaka Kawano : Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia., International Orthopaedics, Vol.41, No.12, 2597-2603, 2017. ... Hiroshi Kobayashi, Toru Akiyama, Tomotake Okuma, Yusuke Shinoda, Hiroyuki Oka, Nobuaki Ito, Seiji Fukumoto, Sakae Tanaka and Hirotaka Kawano : Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones., Computer Assisted Surgery, Vol.22, No.1, 14-19, 2017. ... Yuka Kinoshita and Seiji Fukumoto : X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases -Prospect for new treatment., Endocrine Reviews, Vol.39, No.3, 274-291, Jan. 2018. ... Seiji Fukumoto : Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?, Frontiers in Endocrinology, Vol.9, (号), 48, Feb. 2018. ... 福本 誠二 : 抗スクレロスチン抗体, 第2回日本CKD-MBD研究会学術集会・総会, 2018年3月. ... Takuo Kubota, Hirofumi Nakayama, Taichi Kitaoka, Yosikazu Nakamura, Seiji Fukumoto, Ikuma Fujiwara, Yukihiro Hasegawa, Kenji Ihara, Sachiko Kitanaka, Satomi Koyama, Satoshi Kusuda, Haruo Mizuno, Keisuke Nagasaki, Koji Oba, Yuko Sakamoto, Noriyuki Takubo, Toshiaki Shimizu, Yusuke Tanahashi, Kosei Hasegawa, Hirokazu Tsukahara, Tohru Yorifuji, Toshimi Michigami and Keiichi Ozono : Incidence rate and characteristics of symptomatic vitamin D deficiency in children: a nationwide survey in Japan., Endocrine Journal, (巻), (号), (頁), 2018. ... 福本 誠二 : FGF23にようるミネラル代謝調節機構, 第91回日本内分泌学会学術総会, 2018年4月. ... Seiji Fukumoto : The Biology of FGF23, Keystone Symposia - Novel Aspects of Bone Biology, (都市), June 2018. ... 福本 誠二 : FGF23∼臨床から基礎へ，そして未来へ∼, 第63回日本透析医学会学術集会・総会, 2018年7月. ... Yuichi Takashi and Seiji Fukumoto : FGF23 beyond Phosphotropic Hormone., Trends in Endocrinology and Metabolism, Vol.29, No.11, 755-767, 2018. ... 福本 誠二 : 腫瘍性骨軟化症(tumor-induced ostomalacia: TIO)の病因, 第22回日本臨床内分泌病理学会学術総会, 2018年9月. ... Nobuaki Ito, Yasuo Imanishi, Yasuhiro Takeuchi, Yutaka Takahashi, Y Rhee, CS Shin, H Kanda and Seiji Fukumoto : Effects of burosumab, an anti-FGF23 antibody, in patients with tumor-induced osteomalacia: Resuults from an ongoing phase 2 study, ASBMR2018, (都市), Sep. 2018. ... Itsuro Endo, Bingzi Dong, Yukiyo Ohnishi, Yukari Ooguro, Kurahashi Kiyoe, Hiasa Masahiro, Junpei Teramachi, Tenshin Hirofumi, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto : Persistent activation of calcium-sensing receptor increases microcrack and decreases bone strength, ASBMR 2018 Annual Meeting, Mnrtial, QU, Oct. 2018. ... Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Zhengju Fu, Toshio Matsumoto and Yangang Wang : Calcilytic, calcium-sensing receptor antagonist, enhances bone remodeling and increases bone mineral density without increasing urinary calcium excretion., ASBMR 2018 Annual Meeting, Mnrtial, QU, Oct. 2018. ... Seiji Fukumoto : Phosphate Metabolism, Hyperphosphatemia, and Hypophosphatemia, Academic Press, Oxford, Oct. 2018. ... Seiji Fukumoto : Regulatory mechanism of phosphate metabolism, 9th International Conference on Osteoporosis and Bone Research, 2018, Suzhou,China, Oct. 2018. ... 福本 誠二 : 癌治療に伴う骨粗鬆症に対する薬物療法, 第20回日本骨粗鬆症学会, 2018年10月. ... 福本 誠二 : ビタミンDの作用と骨粗鬆症, 第20回日本骨粗鬆症学会, 2018年10月. ... 福本 誠二 : CTIBL, 第20回日本骨粗鬆症学会, 2018年10月. ... (未承認) 福本 誠二, Toshio Matsumoto : Cancer treatment-induced bone loss (CTIBL), Japanese Journal of Cancer and Chemotherapy, Vol.45, No.12, 1685-1689, 2018年. ... Yuka Kinoshita, Yuichi Takashi, Nobuaki Ito, Shiro Ikegawa, Hiroyuki Mano, Tetsuo Ushiku, Masashi Fukayama, Masaomi Nangaku and Seiji Fukumoto : Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)., Bone Reports, Vol.10, 100192, 2018. ... 福本 誠二 : FGF23関連低リン血症性疾患患者の治療, 第92回日本内分泌学会学術総会, 2019年5月. ... 髙士 祐一, 小迫 英尊, 沢津橋 俊, 木下 祐加, 伊東 伸朗, 安倍 正博, 松久 宗英, 加藤 茂明, 松本 俊夫, 福本 誠二 : FGFR1はFGF23濃度調節を媒介するリン感知受容体である, 第92回日本内分泌学会学術総会, Vol.95, No.1, 333, 2019年5月. ... 金井 麻衣, 松岡 飛翔, 遠藤 逸朗, 大西 幸代, 髙士 祐一, 倉橋 清衛, 吉田 守美子, 粟飯原 賢一, 安倍 正博, 福本 誠二, 松本 俊夫 : 鉄製剤投与によるFGF23関連低リン血症モデル作成の試み, 第92回日本内分泌学会学術総会, Vol.95, No.1, 422, 2019年5月. ... Seiji Fukumoto : New insights into the FGF23 health and disease, ECTS 2019, Budapest, May 2019. ... Seiji Fukumoto : Hypophosphatemic rickets/osteomalacia -Pathogenesis and new treatment-, The 7th Seoul Symposium on Bone Health, Seoul, May 2019. ... Maria Tsoumpra, Seiji Fukumoto, Toshio Matsumoto, Shin'ichi Takeda, Matthew J. A. Wood and Yoshitsugu Aoki : Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases., EBioMedicine, Vol.45, (号), 630-645, 2019. ... 福本 誠二 : ミネラル代謝異常症診療の進歩, 一般社団法人日本骨代謝学会 教育講演会, 2019年7月. ... Seiji Fukumoto : Fibroblast growth factor 23, Academic Press, (都市), Aug. 2019. ... Chang Liu, Zhen Zhao, Ou Wang, Mei Li, Xiaoping Xing, Evelyn Hsieh, Seiji Fukumoto, Yan Jiang and Weibo Xia : Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature., Calcified Tissue International, Vol.105, No.5, 476-486, 2019. ... Mai Kanai, Itsuro Endo, Yasuko Takahashi, Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto : Establishment of model mice of FGF23-related hypophosphatemia induced by iron solution administration, ASBMR 2019, (巻), (号), (頁), Orlando, Sep. 2019. ... Minae Koga, Hajime Kato, Nobuaki Ito, Yuka Kinoshita and Seiji Fukumoto : The utility of SRS/SRPET and systemic FG23 venous sampling for tumor localization in 20 consecutive tumor-induced osteomalacia cases, ASBMR 2019, (巻), (号), (頁), Orlando, Sep. 2019. ... Maria Tsoumpra, Michihiro Imamura, Yoshitaka Mizobe, Shin'ichi Takeda, Yoshitsugu Aoki, Seiji Fukumoto and Toshio Matsumoto : The vitamin D - vitamin D receptor axis positively regulates the expression of dystrobrevin alpha during murine myogenic differentiation, ASBMR 2019, (巻), (号), (頁), Orlando, Sep. 2019. ... 福本 誠二 : FGF23とリン代謝, 第49会日本腎臓学会東部学術大会, (巻), (号), (頁), 2019年10月. ... 福本 誠二 : 骨形成促進薬としてのアバロパラチド, 第21回日本骨粗鬆症学会, (巻), (号), (頁), 2019年10月. ... 飯沼 典雄, 福本 誠二, 上村 夕香理, 田中 司朗, 藤原 佐枝子, 松本 俊夫, 折茂 肇 : 各年齢における骨粗鬆症患者の新規骨折発生に影響する因子-A-TOP研究登録の患者データを活用した解析(第2報)-, 第21回日本骨粗鬆症学会, (巻), (号), (頁), 2019年10月. ... 高谷 理依子, 皆川 真規, 窪田 拓生, 井上 大輔, 杉本 利嗣, 福本 誠二, 大薗 恵一, 中村 好一 : 偽性副甲状腺機能低下症とその類縁疾患および副甲状腺機能低下症の全国アンケート調査, 第38回日本骨代謝学会学術集会, (巻), (号), (頁), 2019年10月. ... 福本 誠二 : 癌治療関連骨減少症の管理, 第38回日本骨代謝学会学術集会, (巻), (号), (頁), 2019年10月. ... 髙士 祐一, 沢津橋 俊, 遠藤 逸朗, 安倍 正博, 松久 宗英, 松本 俊夫, 福本 誠二 : FGFR1は血中FGF23濃度を制御するリン感知受容体である, 第38回日本骨代謝学会学術集会, (巻), (号), (頁), 2019年10月. ... 高谷 理依子, 皆川 真規, 窪田 拓生, 井上 大輔, 杉本 利嗣, 福本 誠二, 大薗 恵一, 中村 好一 : 偽性副甲状腺機能低下症とその類縁疾患および副甲状腺機能低下症の全国疫学調査, 第38回日本骨代謝学会学術集会, (巻), (号), (頁), 2019年10月. ... 竹内 靖博, 福本 誠二, 今西 康雄, 西田 雄一, 近藤 雄一朗 : 副甲状腺癌及び難治性の原発性副甲状腺機能亢進症患者における高カルシウム血症に対するエボカルセトの有効性と安全性, 第38回日本骨代謝学会学術集会, (巻), (号), (頁), 2019年10月. ... Seiji Fukumoto : FGF23-related hypophosphatemic diseases: Prospect for new treatment, SfE BES 2019, (巻), (号), (頁), Brighton, Nov. 2019. ... 福本 誠二 : 骨・ミネラル代謝と内分泌学, Skeletal Science Retreat, (巻), (号), (頁), 2019年11月. ... 福本 誠二 : 骨粗鬆症の最新治療-多様な治療薬の作用と選択-, 第29回臨床内分泌代謝Update in Kochi, (巻), (号), (頁), 2019年11月. ... 倉橋 清衛, 青山 万里子, 滝沢 宏光, 遠藤 ふうり, 三井 由香里, 桝田 志保, 吉田 守美子, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 安倍 正博, 福本 誠二 : 薬物治療に抵抗性で，日和見感染も合併したバセドウ病の一例, 第29回臨床内分泌代謝Update in Kochi, (巻), (号), (頁), 2019年11月. ... 三井 由香里, 辻本 賀美, 工藤 千晶, 安井 沙耶, 遠藤 ふうり, 桝田 志保, 倉橋 清衛, 吉田 守美子, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 安倍 正博, 福本 誠二 : 治療拒否により甲状腺クリーゼを繰り返したバセドウ病の1例, 第29回臨床内分泌代謝Update in Kochi, 2019年11月. ... 辻本 賀美, 三井 由香里, 工藤 千晶, 安井 沙耶, 遠藤 ふうり, 桝田 志保, 倉橋 清衛, 吉田 守美子, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 安倍 正博, 福本 誠二 : 免疫関連有害事象の末ロイド治療中ACTH分泌低下症を認めた1例, 第29回臨床内分泌代謝Update in Kochi, 2019年11月. ... 工藤 千晶, 倉橋 清衛, 辻本 賀美, 安井 沙耶, 遠藤 ふうり, 三井 由香里, 桝田 志保, 吉田 守美子, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 安倍 正博, 福本 誠二 : ニボルマブ投与により3系統の内分泌障害を発症した2例, 第29回臨床内分泌代謝Update in Kochi, 2019年11月. ... 遠藤 ふうり, 吉田 守美子, 辻本 賀美, 工藤 千晶, 安井 沙耶, 桝田 志保, 三井 由香里, 倉橋 清衛, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 安倍 正博, 福本 誠二 : ソマトスタチンアナログ治療中に胆嚢癌を認めた先端巨大症の1例, 第29回臨床内分泌代謝Update in Kochi, 2019年11月. ... Seiji Fukumoto, Yuichi Takashi, Maria Tsoumpra, Shun Sawatsubashi and Toshio Matsumoto : How do we sense phosphate to regulate serum phosphate level?, Journal of Bone and Mineral Metabolism, Vol.38, No.1, 1-6, 2020. ... Pablo Florenzano, Cristiana Cipriani, Kelly L. Roszko, Seiji Fukumoto, Michael T. Collins, Salvatore Minisola and Jessica Pepe : Approach to patients with hypophosphataemia., The Lancet. Diabetes & Endocrinology, Vol.8, No.2, 163-174, 2020. ... Nobuaki Ito and Seiji Fukumoto : Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23., Calcified Tissue International, Vol.108, No.1, 104-115, 2020. ... Seiji Fukumoto, Satoshi Soen, Tetsuya Taguchi, Takashi Ishikawa, Hisashi Matsushima, Masakazu Terauchi, Shigeo Horie, Toshiyuki Yoneda, Toshitsugu Sugimoto and Toshio Matsumoto : Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR., Journal of Bone and Mineral Metabolism, Vol.38, No.2, 141-144, 2020. ... (未承認) Y. Takashi and Seiji Fukumoto : Phosphate-sensing and regulatory mechanism of FGF23 production, Journal of Endocrinological Investigation, Vol.43, No.7, 877-883, March 2020. ... Maria Tsoumpra, Shun Sawatsubashi, Michihiro Imamura, Seiji Fukumoto, Shin'ichi Takeda, Toshio Matsumoto and Yoshitsugu Aoki : Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle., Journal of Molecular Endocrinology, Vol.64, No.3, 195-208, 2020. ... Yasuhiro Takeuchi, Yuichi Nishida, Yuichiro Kondo, Yasuo Imanishi and Seiji Fukumoto : Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study., Journal of Bone and Mineral Metabolism, Vol.38, No.5, 687-694, 2020. ... Seiji Fukumoto : The Bone-FGF23-Klotho Axis and Associated Diseases, Academic Press, (都市), June 2020. ... Takuo Kubota, Seiji Fukumoto, Hae Il Cheong, Toshimi Michigami, Noriyuki Namba, Nobuaki Ito, Shin Tokunaga, Yoshimi Gibbs and Keiichi Ozono : Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study., BMJ Open, Vol.10, No.6, e036367, 2020. ... Yuichi Takashi and Seiji Fukumoto : Fibroblast growth factor receptor as a potential candidate for phosphate sensing., Current Opinion in Nephrology and Hypertension, Vol.29, No.4, 446-452, 2020. ... 吉田 守美子, 工藤 千晶, 辻本 賀美, 安井 沙耶, 遠藤 ふうり, 桝田 志保, 三井 由香里, 倉橋 清衛, 黒田 暁生, 明比 祐子, 遠藤 逸朗, 粟飯原 賢一, 松久 宗英, 安倍 正博, 福本 誠二 : 糖尿病教育入院でのテストステロン値の変化の検討, 第93回日本内分泌学会学術総会, Vol.96, No.1, 287, 2020年7月. ... 三井 由香里, 飯塚 裕斗, 田中 智明, 遠藤 逸朗, 倉橋 清衛, 吉田 守美子, 山口 佑樹, 山上 紘規, 藤中 雄一, 森本 佳奈, 白神 敦久, 福本 誠二, 松本 俊夫 : CRH負荷試験による副腎皮質機能低下症·不全症カットオフ値策定の試み, 第93回日本内分泌学会学術総会, Vol.96, No.1, 251, 2020年7月. ... 沢津橋 俊, 松本 俊夫, 福本 誠二 : 栄養情報が調節するグルココルチコイド受容体の転写制御機構の解析, 第93回日本内分泌学会学術総会, Vol.96, No.1, 238, 2020年7月. ... 福本 誠二, 高士 祐一 : FGF23クローニングからの20年: 基礎研究における最近の知見, 第93回日本内分泌学会学術総会, 2020年7月. ... Yasuo Imanishi, Nobuaki Ito, Yumie Rhee, Yasuhiro Takeuchi, Chan Soo Shin, Yutaka Takahashi, Hiroki Onuma, Masahiro Kojima, Masanori Kanematsu, Hironori Kanda, Yoshiki Seino and Seiji Fukumoto : Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia., Journal of Bone and Mineral Research, Vol.36, No.2, 262-270, 2020. ... Seiji Fukumoto : FGF23 and Bone and Mineral Metabolism., Handbook of Experimental Pharmacology, Vol.262, (号), 281-308, 2020. ... Yoshiaki Kanemoto, Akira Hayakawa, Takahiro Sawada, Rei Amano, Tomohiro Kurokawa, Shun Sawatsubashi, Seiji Fukumoto, Jinichi Mori and Shigeaki Kato : Transcriptional Regulation of 25-Hydroxyvitamin D-24-Hydroxylase (CYP24A1) by Calcemic Factors in Keratinocytes., Journal of Nutritional Science and Vitaminology, Vol.67, No.6, 424-428, 2021. ... (未承認) Seiji Fukumoto : Klotho-the discovery of the FGF23 coreceptor, (発行所), (都市), Jan. 2021. ... Seiji Fukumoto : FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment., Journal of Molecular Endocrinology, Vol.66, No.2, R57-R65, 2021. ... Hajime Kato, Minae Koga, Yuka Kinoshita, Yuki Taniguchi, Hiroshi Kobayashi, Seiji Fukumoto, Masaomi Nangaku, Noriko Makita and Nobuaki Ito : Incidence of complications in 25 adult patients with X-linked hypophosphatemia., The Journal of Clinical Endocrinology and Metabolism, (巻), (号), (頁), 2021. ... Nobuaki Ito, Takuo Kubota, Sachiko Kitanaka, Ikuma Fujiwara, Masanori Adachi, Yasuhiro Takeuchi, Hitomi Yamagami, Takehide Kimura, Tatsuya Shinoda, Masanori Minagawa, Ryo Okazaki, Keiichi Ozono, Yoshiki Seino and Seiji Fukumoto : Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23., Journal of Bone and Mineral Metabolism, Vol.39, No.6, 1066-1075, 2021. ... Yuichi Takashi, Shun Sawatsubashi, Itsuro Endo, Yukiyo Ohnishi, Masahiro Abe, Munehide Matsuhisa, Daiji Kawanami, Toshio Matsumoto and Seiji Fukumoto : Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span., Biochemistry and Biophysics Reports, Vol.27, 101107, 2021. ... Naoko Hidaka, Hajime Kato, Minae Koga, Masaki Katsura, Yuko Oyama, Yuka Kinoshita, Seiji Fukumoto, Noriko Makita, Masaomi Nangaku and Nobuaki Ito : Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption., Bone Reports, Vol.15, (号), 101144, 2021. ... Yuichi Takashi, Daiji Kawanami and Seiji Fukumoto : FGF23 and Hypophosphatemic Rickets/Osteomalacia., Current Osteoporosis Reports, (巻), (号), (頁), 2021. ... Xiaolin Ni, Yiming Feng, Wenmin Guan, Yue Chi, Xiang Li, Yiyi Gong, Nan Zhao, Qianqian Pang, Wei Yu, Huanwen Wu, Li Huo, Yong Liu, Jin Jin, Xi Zhou, Wei Lv, Lian Zhou, Yu Xia, Wei Liu, Ruizhi Jiajue, Ou Wang, Mei Li, Xiaoping Xing, Seiji Fukumoto, Yan Jiang and Weibo Xia : Bone Impairment in a Large Cohort of Chinese Patients with Tumor-induced Osteomalacia Assessed by HR-pQCT and TBS., Journal of Bone and Mineral Research, (巻), (号), (頁), 2021. ... Yuichi Takashi and Seiji Fukumoto : Phosphate-Sensing., Advances in Experimental Medicine and Biology, Vol.1362, (号), 27-35, 2022. ... Yukari Mitsui, Yuto Iizuka, Tomoaki Tanaka, Tomoyo Hara, Shiho Masuda, Yukiyo Ohnishi, Mai Kanai, Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Kondo, Toshiko Kanezaki, Yasumi Shintani, Hiroki Yamagami, Hiroyuki Yamaguchi, Yuichi Fujinaka, Kana Morimoto, Atsuhisa Shirakami, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Itsuro Endo : An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluation., The Journal of Medical Investigation : JMI, Vol.69, No.3.4, 287-293, 2022. ... Naoko Hidaka, Minae Koga, Soichiro Kimura, Yoshitomo Hoshino, Hajime Kato, Yuka Kinoshita, Noriko Makita, Masaomi Nangaku, Kazuhiko Horiguchi, Yasushi Furukawa, Keizo Ohnaka, Kenichi Inagaki, Atsushi Nakagawa, Atsushi Suzuki, Yasuhiro Takeuchi, Seiji Fukumoto, Fumihiko Nakatani and Nobuaki Ito : Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance., Journal of Bone and Mineral Research, (巻), (号), (頁), 2022. ... Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, Suzanne Beur M. Jan De, Seiji Fukumoto, Salvatore Minisola, Weibo Xia, Jean-Jacques Body and M Carola Zillikens : Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases., Calcified Tissue International, (巻), (号), (頁), 2022. ... Rieko Takatani, Takuo Kubota, Masanori Minagawa, Daisuke Inoue, Seiji Fukumoto, Keiichi Ozono and Yosikazu Nakamura : Prevalence of pseudohypoparathyroidism and nonsurgical hypoparathyroidism in Japan in 2017: A nationwide survey., Journal of Epidemiology, (巻), (号), (頁), 2022. ... Janice L. Pasieka, Kelly Wentworth, Caitlin T. Yeo, Serge Cremers, David Dempster, Seiji Fukumoto, Ravinder Goswami, Pascal Houillier, Michael A. Levine, Jesse D. Pasternak, Nancy D. Perrier, Antonio Sitges-Serra and Dolores M. Shoback : Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review., Journal of Bone and Mineral Research, (巻), (号), (頁), 2022. ... Salvatore Minisola, Seiji Fukumoto, Weibo Xia, Alessandro Corsi, Luciano Colangelo, Alfredo Scillitani, Jessica Pepe, Cristiana Cipriani and Rajesh V. Thakker : TUMOR-INDUCED OSTEOMALACIA: A COMPREHENSIVE REVIEW., Endocrine Reviews, Vol.44, No.2, 323-353, 2022. ... (未承認) Yuichi Takashi, Kyoko Toyokawa, Naoki Oda, Yoshimi Muta, Hisashi Yokomizo, Seiji Fukumoto and Daiji Kawanami : Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report, Frontiers in Endocrinology, Vol.13, (号), (頁), 2022. ... (未承認) M. de Beur Suzanne Jan, Salvatore Minisola, bo Wei Xia, Bo Abrahamsen, Jacques Jean Body, Luisa Maria Brandi, Roderick Clifton-Bligh, Michael Collins, Pablo Florenzano, Pascal Houillier, Yasuo Imanishi, A. Erik Imel, A. Aliya Khan, Carola M. Zillikens and Seiji Fukumoto : Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia, Journal of Internal Medicine, Vol.293, No.3, 309-328, Dec. 2022. ... (未承認) Ayako Hanai, Ayako Kawabata, Kenta Nakajima, Kazuhiro Masuda, Itaru Urakawa, Masahiro Abe, Yuji Yamazaki and Seiji Fukumoto : Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D3 treatment, Frontiers in Physiology, Vol.14, (号), (頁), 2023. ... (未承認) Hajime Kato, Minae Koga, Yuka Kinoshita, Naoko Hidaka, Yoshitomo Hoshino, Yuichi Takashi, Makoto Arai, Hiroshi Kobayashi, Masaki Katsura, Yuji Nakamoto, Naohiro Makise, Tetsuo Ushiku, Kazuto Hoshi, Masaomi Nangaku, Noriko Makita, Seiji Fukumoto and Nobuaki Ito : Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors, Journal of the Endocrine Society, Vol.7, No.2, (頁), 2023. ... (未承認) Seiji Fukumoto : Recent basic and clinical findings concerning FGF23: A bone-derived hormone, Current Opinion in Endocrine and Metabolic Research, Vol.29, (号), (頁), April 2023. ... (未承認) Hajime Kato, Rena Okawa, Toru Ogasawara, Yoshitomo Hoshino, Naoko Hidaka, Minae Koga, Yuka Kinoshita, Hiroshi Kobayashi, Yuki Taniguchi, Seiji Fukumoto, Masaomi Nangaku, Noriko Makita, Kazuto Hoshi, Kazuhiko Nakano and Nobuaki Ito : Effect of Conventional Treatment on Dental Complications and Ectopic Ossifications Among 30 Adults With XLH, Journal of Clinical Endocrinology and Metabolism, Vol.108, No.6, 1405-1414, 2023. ... (未承認) Seiji Fukumoto, Tatsunori Murata, Yutaka Osuga and F. Richard Pollock : Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials, Advances in Therapy, Vol.40, No.11, 4877-4888, 2023. ... (未承認) Seiji Fukumoto and Yukihiro Hasegawa : Special Issue: ``X-Linked Hypophosphatemia'', (発行所), (都市), Dec. 2023. ... (未承認) Seiji Fukumoto : Tumor-induced osteomalacia, Panminerva Medica, Vol.66, No.2, 188-197, Dec. 2023. ... (未承認) Naoko Hidaka, Kosuke Inoue, Hajime Kato, Yoshitomo Hoshino, Minae Koga, Yuka Kinoshita, Yuichi Takashi, Noriko Makita, Seiji Fukumoto, Masaomi Nangaku and Nobuaki Ito : FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis, JACC: Advances, Vol.3, No.1, (頁), 2024. ... (未承認) Seiji Fukumoto : Regulation of FGF23 Production in Osteocytes, Current Osteoporosis Reports, Vol.22, No.2, 273-279, 2024. ... (未承認) Shun Sawatsubashi, Yuichi Takashi, Itsuro Endo, Takeshi Kondo, Masahiro Abe, Toshio Matsumoto and Seiji Fukumoto : Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause-, Bone, Vol.182, (号), 117057, 2024. ... (未承認) Hisashi Matsushima, Tetsuya Taguchi, Sho Kodama, Naoki Okubo, Kengo Saito, Katarzyna Jabłońska, Seiji Fukumoto and Toshio Matsumoto : Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan, Journal of Bone and Mineral Metabolism, Vol.42, No.2, 223-232, 2024. ... (未承認) Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka and Seiji Fukumoto : The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis, Journal of Bone and Mineral Metabolism, Vol.42, No.2, 143-154, 2024. ... (未承認) Tetsuya Taguchi, Hisashi Matsushima, Sho Kodama, Naoki Okubo, Tetsuo Ito, Maja Ludwikowska, Seiji Fukumoto and Toshio Matsumoto : Osteoporotic fracture risk in women with breast cancer treated with aromatase inhibitors: a health insurance claims database study in Japan, Expert Opinion on Pharmacotherapy, Vol.25, No.3, 325-334, 2024. ... (未承認) Yuichi Takashi, Daiji Kawanami and Seiji Fukumoto : Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders, Current Opinion in Endocrinology, Diabetes and Obesity, Vol.31, No.4, 170-175, April 2024. ... (未承認) Toshimi Michigami, Gyung Hee Kang, Noriyuki Namba, Nobuaki Ito, Takuo Kubota, Ayumi Shintani, Daijiro Kabata, Masanori Kanematsu, Yayoi Nishida, Seiji Fukumoto and Keiichi Ozono : Burosumab treatment of X-linked hypophosphatemia patients: interim analysis of the SUNFLOWER longitudinal, observational cohort study, JBMR Plus, Vol.8, No.8, (頁), 2024. ... (未承認) Noriyuki Namba, Nobuaki Ito, Toshimi Michigami, Gyung Hee Kang, Takuo Kubota, Osamu Miyazaki, Ayumi Shintani, Daijiro Kabata, Yayoi Nishida, Seiji Fukumoto and Keiichi Ozono : Impact of X-linked hypophosphatemic rickets/osteomalacia on health and quality of life: baseline data from the SUNFLOWER longitudinal, observational cohort study, JBMR Plus, Vol.8, No.11, (頁), 2024. ... (未承認) S. Dalal Ali, A. Aliya Khan, D. Reza Mirza, M. Natasha Appelman-Dijkstra, Luisa Maria Brandi, O. Thomas Carpenter, Catherine Chaussain, A. Erik Imel, M.Jan Beur Suzanne de, Pablo Florenzano, Archibald Morrison, Abu Hajar Alrob, Todd R. Alexander, Farah Alsarraf, Sparre Signe Beck-Nielsen, Martin Biosse-Duplan, Martine Cohen-Solal, K. Rachel Crowley, Karel Dandurand, Guido Filler, Seiji Fukumoto, Claudia Gagnon, Paul Goodyer, Corinna Grasemann, Chelsey Grimbly, Salma Hussein, K. Muhammad Javaid, Sarah Khan, Aneal Khan, Anna Lehman, F. Willem Lems, Michael E. Lewiecki, Ciara McDonnell, Emmett Morgante, A. Anthony Portale, Yumie Rhee, Heide Siggelkow, Laura Tosi, M. Leanne Ward and Gordon Guyatt : Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults, Journal of Bone and Mineral Metabolism, (巻), (号), (頁), 2025. ... (未承認) Nobuaki Ito, Gyung Hee Kang, Toshimi Michigami, Noriyuki Namba, Takuo Kubota, Ayumi Shintani, Ryota Kawai, Daijiro Kabata, Haruka Ishii, Yayoi Nishida, Seiji Fukumoto and Keiichi Ozono : Prevalence of Comorbid Hyperparathyroidism and Its Association with Renal Dysfunction in Asian Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia, Calcified Tissue International, Vol.116, No.1, 50, 2025. ...
過去3日以内に登録・変更された情報
無効な情報 (18件)
-
T Shimada, S Mizutani, T Muto, T Yoneya, R Hino, S Takeda, Y Takeuchi, T Fujita, S Fukumoto and T Yamashita : Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia., Proceedings of the National Academy of Sciences of the United States of America, Vol.98, No.11, 6500-6505, 2001. (種別) : Takaaki Okamoto, Manabu Taguchi, Tomoko Osaki, Seiji Fukumoto and Toshiro Fujita : Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation., Journal of Bone and Mineral Metabolism, Vol.32, No.4, 393-399, (発行所), (都市), Sep. 2013. (種別) : Rika Jimbo, Fumiko Kawakami-Mori, Shengyu Mu, Daigoro Hirohama, Bohumil Majtan, Yuichiro Shimizu, Yutaka Yatomi, Seiji Fukumoto, Toshiro Fujita and Tatsuo Shimosawa : Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency., Kidney International, Vol.85, No.5, 1103-1111, (発行所), (都市), Oct. 2013. (種別) : Yuka Kinoshita, Michiko Hori, Manabu Taguchi, Sumiyo Watanabe and Seiji Fukumoto : Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia., The Journal of Clinical Endocrinology and Metabolism, Vol.99, No.2, E363-8, (発行所), (都市), Dec. 2013. (種別) : Takeshi Nakamura, Toshimi Aizawa, Takeshi Hoshikawa, Hiroshi Ozawa, Nobuaki Ito, Seiji Fukumoto, Eiji Itoi and Shoichi Kokubun : Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine., Journal of Orthopaedic Science, Vol.20, No.4, 765-771, (発行所), (都市), Feb. 2014. Seiji Fukumoto : Anti-fibroblast growth factor 23 antibody therapy., Current Opinion in Nephrology and Hypertension, Vol.23, No.4, 346-351, 2014. (種別) : Yuka Kinoshita, Michiko Hori, Manabu Taguchi and Seiji Fukumoto : Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia., Bone, Vol.67, (号), 145-151, (発行所), (都市), July 2014. Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Takeshi Kondo, Tomoka Hasegawa, Norio Amizuka, Hiroshi Kiyonari, Go Shioi, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto : Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH)., Journal of Bone and Mineral Research, Vol.30, No.11, 1980-1993, 2015. (種別) : Yuka Kinoshita, Makoto Arai, Nobuaki Ito, Yuichi Takashi, Noriko Makita, Masaomi Nangaku, Yusuke Shinoda and Seiji Fukumoto : High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors., Endocrine Journal, Vol.63, No.5, 479-484, (発行所), (都市), Feb. 2016. (種別) : Takeshi Kondo, Itsuro Endo, Ken-Ichi Aihara, Yukiyo Onishi, Bingzi Dong, Yukari Ohguro, Kiyoe Kurahashi, Sumiko Yoshida, Yuichi Fujinaka, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Toshio Matsumoto and Masahiro Abe : Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors., Endocrine Journal, (巻), (号), (頁), (発行所), (都市), Feb. 2016. Takeshi Kondo, Itsuro Endo, Yukari Ooguro, Kana Morimoto, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Ken-Ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto : Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer., Internal Medicine, Vol.55, No.24, 3623-3626, 2016. Salvatore Minisola, Munro Peacock, Seijii Fukumoto, Cristiana Cipriani, Jessica Pepe, Sri Harsha Tella and Michael T. Collins : Tumour-induced osteomalacia., Nature Reviews. Disease Primers, Vol.3, (号), 17044, July 2017. Shun Sawatsubashi, Yudai Joko, Seiji Fukumoto, Toshio Matsumoto and Shigeo S. Sugano : Development of versatile non-homologous end joining-based knock-in module for genome editing., Scientific Reports, Vol.8, No.1, 593, 2018. Seiji Fukumoto : The Biology of FGF23, Keystone Symposia - Novel Aspects of Bone Biology, (都市), June 2018. Seiji Fukumoto : The Biology of FGF23, Keystone Symposia - Novel Aspects of Bone Biology, (都市), June 2018. 福本 誠二 : 腫瘍性骨軟化症(tumor-induced ostomalacia: TIO)の病因, 第22回日本臨床内分泌病理学会学術総会, 2018年9月. Seiji Fukumoto : Regulatory mechanism of phosphate metabolism, 9th International Conference on Osteoporosis and Bone Research, 2018, (都市), Oct. 2018. Ito Nobuaki : (題名), (誌名), (巻), (号), (頁), (都市), (年月日).
本データベースでは情報の登録，保守作業の分散を主たる目的の一つとしております．したがって，上記にリストアップされている情報の保守は個々の情報の当事者に委ねられます．
ある情報を保守する義務があるかないかは，その情報に対して権限を持っているかどうかで判断してください．もちろん情報の所有者が主に管理しなくてはならないことになりますが，権限を持っている利用者が連帯してその情報の保守を行なう義務を負っていると考えてください．
貴方がどの情報について権限を持っているかは，貴方自身の情報を閲覧してください．
Number of session users = 0, LA = 0.53, Max(EID) = 433640, Max(EOID) = 1154573.